Antimycobacterial activity of the antiinflammatory agent diclofenac sodium, and its synergism with streptomycin

Brazilian Journal of Microbiology

Volumn 35, Issue 4, 2004, Pages 316-323

  Dutta, Noton K ^a   Dastidar, Sujata G ^a   Kumar, Asok ^a   Mazumdar, Kaushiki ^a   Ray, Raja ^b   Chakrabarty, Atindra N ^b  

^a JADAVPUR UNIVERSITY   (India)

^b UNIVERSITY OF CALCUTTA   (India)

Author keywords

Antiinflammatory drug; Antimycobacterial activity; Diclofenac sodium; Non antibiotic; Streptomycin; Synergism

Indexed keywords

CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 25144467579     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822004000300009     Document Type: Article

References (27)

1. Amaral, L.; Kristiansen, J.E.; Abebe, L.S.; Millet, W. Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis. J. Antimicrob. Chemother., 38:1049-1053, 1996.
2. Amaral, L.; Kristiansen, J.E. Phenothiazines. An alternative to conventional management of suspect multi-drug resistant tuberculosis. A call for studies. Int. J. Antimicrob. Agents, 14:173-176, 2000.
3. Annadurai, S.; Basu, S.; Ray, S.; Dastidar, S.G.; Chakrabarty, A.N. Antimicrobial activity of the antiinflammatory agent diclofenac sodium. Indian. J. Exp. Biol., 36:86-90, 1998.
4. Annadurai, S.; Guha-Thakurta, A.; Sa, B.; Dastidar, S.G.; Ray, R.; Chakrabarty, A.N. Experimental studies on synergism between aminoglycosides and the antimicrobial antiinflammatory agent diclofenac sodium. J. Chemother., 14(1):47-53, 2002.
5. Antimicrobial Susceptibility Testing for Mycobacterium tuberculosis: Tentative standard document M24-T, Vol. 15, No.-16. National Committee for Clinical Laboratory Standards (NCCLS). December 1995.
6. Bhattacharya, G.K.; Johnson, R.A. Statistical Concept and Methods. John Wiley and Sons, New York, London, 1977, p.425.
7. Chakrabarty, A.N.; Bhattacharya, C.P.; Dastidar, S.G. Antimycobacterial activity of methdilazine (Md), an antimicrobic phenothiazine. Acta Path. Microbiol. Immun. Scand., 101:449-454, 1993.
8. Crowle, A.J.; Douvas, G.S.; May, M.H. Chlorpromazine: a drug potentially useful for treating mycobacterial infections. Chemother., 38:410-419, 1992.
9. Dastidar, S.G.; Basu, S.; Annadurai, S.; Chakrabarty, A.N. In vitro and in vivo antibacterial activity of the antiinflammatory agent diclofenac sodium. In: Recent advances in chemotherapy. Proceedings of the Eighteenth International Congress of Chemotherapy. Stockholm, Sweden, 1994, pp.339-340.
10. Dastidar, S.G.; Ganguly, K.; Chaudhuri, K.; Chakrabarty, A.N. The antibacterial action of diclofenac shown by inhibition of DNA synthesis. Int. J. Antimicrob. Agents, 14:249-251, 2000.
11. Dastidar, S.G.; Annadurai, S.; Kumar, A.K.; Dutta, N.K.; Chakrabarty, A.N. Evaluation of a synergistic combination between the nonantibiotic microbicides diclofenac and trifluoperazine. Int. J. Antimicrob. Agents, 21(6):601-603, 2003.
12. Dickinsion, J.M.; Mitchison, D.A. In vitro property of rifapentine (MDL 473) relevant to its use in the intermittent chemotherapy of tuberculosis. Tubercule, 113-118, 1987.
13. Fenner, F. The pathogenic behavior of Mycobacterium ulcerans and Mycobacterium balnei in the mouse and the developing chick embryo. Amer. Rev. Tubercul., 73:650-660, 1956.
14. Goodman Gilman, A. In: Hardman, J.G.; Limbird, L.E. and Goodman Gilman, A. (Eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. McGraw- Hill, New York, 2001, Vols. I and II.
15. International Union against Tuberculosis 1955 Year Book 1955. International Union against Tuberculosis, Paris, p.89.
16. Kirchner, O. Die Leistungsfahigkeit der Tiefenkultur des Tuberkelbazillus bei Verwendung besonders geeigneter flussiger Nahrboden. Zentralblat fur Bakt., 124:403-413, 1932.
17. Kristiansen, J.E.; Vergman, B. Antibacterial effect of selected phenothiazines and thioxanthines on slow growing mycobacteria. Acta Path. Microbiol. Immun. Scand., 94:393-398, 1986.
18. Kristiansen, J.E. The antimicrobial activity of non-antibiotics. Acta Path. Microbiol. Scand., 100(Suppl.):7-19, 1992.
19. Krogstad, D.J.; Moellering, R.C. Jr. Combinations of antibiotics, mechanism of interaction against bacteria. In: Lorian, V. (ed). Antibiotics in Laboratory Medicine. Williams and Wilkins, Baltimore, 1980, pp.298-341.
20. Mazumdar, R.; Ganguly, K.; Dastidar, S.G.; Chakrabarty, A.N. Trifluoperazine: a broad-spectrum bactericide specially active on staphylococci and vibrios. Int. J. Antimicrob. Agents, 18:403-406, 2001.
21. Molnár, J.; Mandi, Y.; Király, J. Antibacterial effect of some phenothiazine compounds and the R-factor elimination by chlorpromazine. Acta Microbiol. Acad. Sci. Hung., 23:45-54, 1976.
22. Molnár, J.; Beladi, I.; Foldes, I. Studies on antitubercular action of some phenothiazine derivatives in vitro. Zbl. Bakt. Hyg. I. Abt. Orig. A., 239:521-526, 1977.
23. Oberhofer, T.R. Manual of Practical Medical Microbiology and Parasitology. John Wiley and Sons, Toronto, 1985, p.352.
24. Ratnakar, P.; Murthy, P.S. Antitubercular activity of trifluoperazine, a calmodulin antagonist. FEMS Microbiol. Lett., 76:73-76, 1992.
25. Viveiros, M.; Amaral, L. Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines. Int. J. Antimicrob. Agents, 17:225-228, 2001.
26. Williams, J.D.; Hedges, A.J. Antimicrobial substances. In: Linton, A.H.; Dick, H.M. (eds.). Topley and Wilson's Principles of Bacteriology, Virology and Immunity. Edward Arnold, London, 1990, pp.111-143.
27. Wilson, G.S.; Miles, A.A. Topley and Wilson's Principles of Bacteriology and Immunity. Edward Arnold, London, 1975, p.588.